Low Lactose Infant Formula
OtherLow Lactose Infant Formula
NCT Number: NCT01497314
The purpose of this study is to show that a low lactose milk-based infant formula supports normal growth in healthy term infants.
Looking for future studies?
Notify MeUp to 14 day
All sexes
Interventional
Not applicable
Accelovance Melbourne Site, Melbourne, Florida, United States
Infants will be fed a low lactose milk-based formula for 16 weeks. Growth and formula tolerability will be assessed.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Low Lactose Infant Formula
Time frame: 16 weeks
Time frame: 16 weeks
Time frame: 16 weeks
Time frame: 16 weeks
Assessed by digestive tolerance; general health and well-being; adverse events; concomitant medications
Perrigo Nutritionals
Industry
An Open Label Clinical Study to Evaluate Growth and Safety of a Low Lactose Milk-Based Infant Formula in Healthy Term Infants
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06312059
Growth
New York, United States
View Trial DetailsNCT04316221
Development; Delayed, Growth
Tecpán Guatemala, Departamento de Chimaltenango, Guatemala
View Trial DetailsNCT07302477
Adverse Event, Growth
Chak Four Hundred Fifty-four, Pakistan
View Trial DetailsNCT07296718
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Feeding Intolerance
Bahawalpur, Punjab Province, Pakistan
View Trial Details